(Date:12/2/2009)... secondhand smoke for a prolonged period of time a...t cancer, even in women who never smoked cigarette...re to side-stream smoke could increase risk of bre...Reynolds, Ph.D., senior research scientist at the ...e. "While no single epidemiologic study can answer...
(Date:12/2/2009)...A Smoky Mountain forest,s woodland herb population...est understories recover from logging, according t...gging in portions of the forest nearly 80 years ag...ndary forest floor was similar to that of undistur...fessor of forestry and natural resources, said tha...
(Date:12/2/2009)...sity of Georgia College of Veterinary Medicine hav...pen new avenues for treating Ichthyophthirius mult...tozoan parasite that commonly attacks freshwater f...researchers found that Ich harbors two apparently ...ich are usually found free-living, and Rickettsia,...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Study finds logging effects vary based on a forest's history, climate 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 1STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 3Wonderbox Technologies 28R 29 Announces 2nd Annual Super User of the Year 51803 1Wonderbox Technologies 28R 29 Announces 2nd Annual Super User of the Year 51803 2NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 1NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 2NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 3(Date:12/2/2009)..., , CAMBRIDGE, Mass., Dec. 2 /PRNewsw...her the leaders in technology development and prod...d MEMS, announced the December 11th deadline for t..., Now in its 14th year, TechConnect World, in as...titute (NSTI), and the Clean Technology and Sustai...
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 ...on its novel oral JAK2 inhibitor, SB1518, at The A...and Exposition in New Orleans. ,, Data will be ... dose-escalation trial of SB1518 detailing its saf...mic (PK/PD) profile in dose levels ranging from 10...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewswi..." or the "Company") (NYSE: SCR ), a leading phar..., manufacturing, and marketing of branded,generic ...nounced that 105 of,its drugs have been included i...), which was issued by China,s Ministry of Human R...
(Date:12/2/2009)..., , SHANGHAI, Dec. 2 /PRNewswire-Asi...es; markets are in turmoil and uncertainty is part...hat the pharma industry has been,relatively immune... take a,vacation. , During the midst of t...iant Johnson & Johnson inaugurated an R&D ...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3... Terry H. Landowski, Ibrahim Buyuksal, and W...d Research Institute, University of South,Florid... , Introduction , Identifyi...n important , strategy in determining the... including cancer. Several techniques have bee...
... Paul Zoller and Theresa Redila-Flores , ...547 USA , , Introduction ,...DGGE) is one of several methods , that ca...ce changes or , point mutations. In DGGE,...ation , of uniform temperature and a line...
... Fang-Fang Wu, Xuemei He, and David R Nau, B...94547 USA, , Introduction ,... (IMAC) is a powerful technique , that ca...inant histidine-tagged , (His-tagged) pro... The synthesis of IMAC resins begins with the d...
Other Biology Technology:Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 2Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 3Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 4Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 5DGGE Analysis Using the DCode System, Rev B 2DGGE Analysis Using the DCode System, Rev B 3Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins 2Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins 3Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins 4di-3-ANEPPDHQ from Molecular Probes (Invitrogen)
REact 2 Buffer from Invitrogen
Phosphate Colorimetric Assay Kit from R&D Systems
Feline IL-10 ELISpot Development Kit from R&D Systems
Biology Products: